Nuclear translocation of p90Rsk and phosphorylation of CREB is induced by ionomycin in a Ras-independent manner in

G Boglári1, J Szeberényi

  • 1Department of Medical Biology, Faculty of Medicine, University of Pécs, Hungary.

Acta Biologica Hungarica
|October 10, 2002
PubMed

Insights

The p90Rsk kinase plays a role in neuronal differentiation of PC12 cells, particularly when Ras protein is blocked. It may substitute for ERK pathways in nerve growth factor (NGF) and ionomycin-induced differentiation.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Neuronal differentiation is crucial for nervous system development.
  • Nerve growth factor (NGF) typically induces neuronal differentiation in PC12 cells via the Ras/MAPK/ERK pathway.
  • PC12-M17 cells with blocked Ras signaling fail to differentiate with NGF alone, but respond to NGF plus ionomycin.

Purpose of the Study:

  • To investigate the role of p90Rsk in neuronal differentiation.
  • To explore alternative signaling pathways in Ras-blocked PC12 cells.

Main Methods:

  • Utilized PC12 and PC12-M17 cells.
  • Induced differentiation with NGF and ionomycin.
  • Assessed p90Rsk nuclear translocation.
  • Measured cAMP response element binding protein (CREB) phosphorylation.

Main Results:

  • Ionomycin induced p90Rsk nuclear translocation in both cell types.
  • Nuclear p90Rsk correlated with increased CREB phosphorylation.
  • This suggests a role for p90Rsk in Ras-independent differentiation.

Conclusions:

  • p90Rsk may compensate for ERK pathway inhibition in neuronal differentiation.
  • p90Rsk could be a key kinase in Ras-independent NGF/ionomycin signaling.
  • This finding expands our understanding of neuronal differentiation signaling.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...